Arcutis Biotherapeutics (ARQT)
Arcutis to Present New Quality of Life and Long-Term Data withZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference
Arcutis to Present New Quality of Life and Long-Term Data withZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference
There are no comments here yet...